Targeting IDH mutations for the treatment of AML
Genomics and acute leukemia management: artificial intelligence, deep learning & pre-leukemic clones
Ari Melnick et al.
Personalising treatment to the biology of the NHL patient
IDH inhibition in AML therapy
Topics in multiple myeloma discussed at ASCO 2016